BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2965731)

  • 1. Poly-N-acetyllactosamine structures on murine cell surface T200 glycoprotein participate in natural killer cell binding to YAC-1 targets.
    Gilbert CW; Zaroukian MH; Esselman WJ
    J Immunol; 1988 Apr; 140(8):2821-8. PubMed ID: 2965731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.
    Fast LD; Beatty P; Hansen JA; Newman W
    J Immunol; 1983 Nov; 131(5):2404-10. PubMed ID: 6415167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
    Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
    J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
    Kiyohara T; Dennis JW; Boegman RJ; Roder JC
    J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
    Roozemond RC; van der Geer P; Bonavida B
    J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Ly-5 glycoprotein in murine natural killer (NK) cell development, target binding and cytotoxicity.
    Zaroukian MH; Gilbert CW; Esselman WJ
    Immunol Invest; 1986 Dec; 15(8):813-32. PubMed ID: 3596678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel antigenic cell surface protein associated with T200 is involved in the post-activation stage of human NK cell-mediated lysis.
    Burns GF; Werkmeister JA; Triglia T
    J Immunol; 1984 Sep; 133(3):1391-6. PubMed ID: 6379048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
    Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
    J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity.
    Seaman WE; Talal N; Herzenberg LA; Herzenberg LA; Ledbetter JA
    J Immunol; 1981 Sep; 127(3):982-6. PubMed ID: 6790624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saccharide structures of the mouse embryo during the first eight days of development. Inferences from immunocytochemical studies using monoclonal antibodies in conjunction with glycosidases.
    Pennington JE; Rastan S; Roelcke D; Feizi T
    J Embryol Exp Morphol; 1985 Dec; 90():335-61. PubMed ID: 3009679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of class I MHC by NK receptor Ly-49C: identification of critical residues.
    Lian RH; Li Y; Kubota S; Mager DL; Takei F
    J Immunol; 1999 Jun; 162(12):7271-6. PubMed ID: 10358175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L; Lemieux S
    J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.